3 documents found, page 1 of 1
Inter rater disagreements in applying the montreal classification for Crohn's d...
Ukashi, Offir; Amiot, Aurelien; Laharie, David; Menchén, Luis; Gutiérrez, Ana; Fernandes, Samuel; Pessarelli, Tommaso; Correia, FábioBackground: The Montreal classification has been widely used in Crohn's disease since 2005 to categorize patients by the age of onset (A), disease location (L), behavior (B), and upper gastrointestinal tract and perianal involvement. With evolving management paradigms in Crohn's disease, we aimed to assess the performance of gastroenterologists in applying the Montreal classification. Methods: An online survey ...
Rates of adverse events in patients with Ulcerative Colitis undergoing colectom...
Dragoni, Gabriele; Innocenti, Tommaso; Amiot, Aurelién; Castiglione, Fabiana; Melotti, Laura; Festa, Stefano; Savarino, Edoardo Vincenzo; Truyens, MarieINTRODUCTION: Patients with ulcerative colitis (UC) receiving immunosuppressive drugs are at substantial risk of colectomy. We aimed to assess the risk of postoperative complications of tofacitinib exposure before colectomy in comparison with biologics. METHODS: A multicenter, retrospective, observational study was conducted in patients with UC who underwent total colectomy for medically refractory disease, exp...
Thiopurines: Use them or lose them? International survey on current and future ...
Sousa, Paula; Ministro, Paula; Armuzzi, Alessandro; Dignass, Axel; Høivik, Marte Lie; Barreiro-de Acosta, Manuel; Vavricka, StephanMade available in DSpace on 2022-04-29T08:30:08Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01; Background and aims: The role of thiopurines in therapeutic algorithms of Crohn's disease (CD) and Ulcerative colitis (UC) is being questioned. This work aimed to investigate current practice and future perspectives of Inflammatory Bowel Disease (IBD) physicians regarding the efficacy, safety, and role ...